Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related mortality and
has an increasing incidence worldwide. Locoregional therapies, defined as imaging-guided …
has an increasing incidence worldwide. Locoregional therapies, defined as imaging-guided …
[HTML][HTML] 2018 Korean Liver Cancer Association–National Cancer Center Korea practice guidelines for the management of hepatocellular carcinoma
Korean Liver Cancer Association - Korean Journal of Radiology, 2019 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …
Percutaneous treatment of hepatocellular carcinoma: state of the art and innovations
JC Nault, O Sutter, P Nahon, N Ganne-Carrié… - Journal of …, 2018 - Elsevier
Percutaneous treatment of hepatocellular carcinoma (HCC) encompasses a vast range of
techniques, including monopolar radiofrequency ablation (RFA), multibipolar RFA …
techniques, including monopolar radiofrequency ablation (RFA), multibipolar RFA …
Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial
Purpose To compare radiofrequency ablation (RFA) with or without transcatheter arterial
chemoembolization (TACE) in the treatment of hepatocellular carcinoma (HCC). Patients …
chemoembolization (TACE) in the treatment of hepatocellular carcinoma (HCC). Patients …
Hepatocellular carcinoma: current management and perspectives for the future
NN Rahbari, A Mehrabi, NM Mollberg, SA Müller… - Annals of …, 2011 - journals.lww.com
Objective: To review the literature on current management of hepatocellular carcinoma
(HCC). Background: Hepatocellular carcinoma represents one of the most common …
(HCC). Background: Hepatocellular carcinoma represents one of the most common …
Local-regional treatment of hepatocellular carcinoma
R Lencioni, L Crocetti - Radiology, 2012 - pubs.rsna.org
Local-regional treatments play a key role in the management of hepatocellular carcinoma
(HCC). Image-guided tumor ablation is recommended in patients with early-stage HCC …
(HCC). Image-guided tumor ablation is recommended in patients with early-stage HCC …
The 10-year survival analysis of radiofrequency ablation for solitary hepatocellular carcinoma 5 cm or smaller: primary versus recurrent HCC
XM Bai, M Cui, W Yang, H Wang, S Wang, ZY Zhang… - Radiology, 2021 - pubs.rsna.org
Background Although favorable outcomes have been reported with radiofrequency ablation
(RFA) for limited hepatocellular carcinoma (HCC), the efficacy of this treatment for recurrent …
(RFA) for limited hepatocellular carcinoma (HCC), the efficacy of this treatment for recurrent …
Insufficient radiofrequency ablation promotes hepatocellular carcinoma metastasis through N6‐methyladenosine mRNA methylation‐dependent mechanism
T Su, M Huang, J Liao, S Lin, P Yu, J Yang, Y Cai… - …, 2021 - Wiley Online Library
Background and Aims The dynamic N6‐methyladenosine (m6A) mRNA modification is
essential for acute stress response and cancer progression. Sublethal heat stress from …
essential for acute stress response and cancer progression. Sublethal heat stress from …
Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma
JH Wang, CC Wang, CH Hung, CL Chen, SN Lu - Journal of hepatology, 2012 - Elsevier
BACKGROUND & AIMS: To compare the survival between surgical resection (SR) and
radiofrequency ablation (RFA) in patients with hepatocellular carcinoma (HCC) in Barcelona …
radiofrequency ablation (RFA) in patients with hepatocellular carcinoma (HCC) in Barcelona …
[HTML][HTML] 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Korean Liver Cancer Association - Korean Journal of Radiology, 2022 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …